http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-506540-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b172e4dc6f8b115773eb99a04e8260f6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-24
filingDate 1968-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88382eaeae194c028387cfb09624c765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9d0bf0d5e86beffbd6c023b1f8db2ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba77ee187b34448fde9cab32c18d5322
publicationDate 1971-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-506540-A
titleOfInvention Process for the preparation of 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
abstract Prepn. of 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one (I) of the formula: by treating 2-glycylamino-5-nitro-benzophenone (II) with agents which release protons (pref. weak or strong organic or inorganic acids such as HCOOH, AcOH, H3PO4, hydrohalic acids and H2SO4). Anticonvulsant, muscle-relaxant, hypnotic. Very good yields (>=80%), high purity. (II) may be readily obtd. in very good yields and in high purity, e.g. from 2-(O-arylsulphonyl-glycoloylamino)-5-nitrobenzophenones (III) and NH3. (II) need not be isolated before cyclisation to (I) (e.g. (III) can be reacted with NH3 in dioxan as solvent, then excess NH3 flushed from the reaction mixture with air and the reaction mixture acidified to cause cyclisation to (I)).
priorityDate 1967-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415758981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416041520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164092129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421024325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465926784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421025396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID618040

Total number of triples: 42.